Business Segments · Goodwill, Acquired During Period

Pharmaceutical and Specialty Solutions — Goodwill, Acquired During Period

Cardinal Health Pharmaceutical and Specialty Solutions — Goodwill, Acquired During Period decreased by 100.5% to -$9.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.3%, from $3.42B to -$9.00M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ3 2022
Last reportedQ1 2026

How to read this metric

Higher values indicate aggressive inorganic growth and capital deployment into new business units.

Detailed definition

The amount of goodwill recognized specifically from business acquisitions completed during the current reporting period...

Peer comparison

Varies significantly based on the timing of M&A cycles within the pharmaceutical wholesale industry.

Metric ID: cah_segment_pharmaceutical_and_specialty_solutions_goodwill_acquired_during_period

Historical Data

15 periods
 Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$198.25M$198.25M$198.25M$198.25M$0.00$763.00M$3.42B$208.00M$21.00M$1.90B-$9.00M
QoQ Change+0.0%+0.0%+0.0%-100.0%+348.0%-93.9%-89.9%>999%-100.5%
YoY Change-100.0%+284.9%>999%+4.9%+148.6%-100.3%
Range-$9.00M$3.42B
Avg YoY Growth+310.4%
Median YoY Growth+76.8%

Frequently Asked Questions

What is Cardinal Health's pharmaceutical and specialty solutions — goodwill, acquired during period?
Cardinal Health (CAH) reported pharmaceutical and specialty solutions — goodwill, acquired during period of -$9.00M in Q1 2026.
How has Cardinal Health's pharmaceutical and specialty solutions — goodwill, acquired during period changed year-over-year?
Cardinal Health's pharmaceutical and specialty solutions — goodwill, acquired during period decreased by 100.3% year-over-year, from $3.42B to -$9.00M.
What does pharmaceutical and specialty solutions — goodwill, acquired during period mean?
The value of goodwill added to the balance sheet from new acquisitions made during the current period.